Log in
Enquire now
‌

US Patent 11873341 Anti-CD25 for tumour specific cell depletion

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118733410
Patent Inventor Names
Pascal Merchiers0
Sergio Quezada0
Anne Goubier0
Kevin Moulder0
Beatriz Goyenechea Corzo0
Josephine Salimu0
Date of Patent
January 16, 2024
0
Patent Application Number
169799320
Date Filed
March 13, 2019
0
Patent Citations
‌
US Patent 10738125 Anti-CD25 antibody agents
0
‌
US Patent 10752691 Anti-CD25 antibody agents
0
‌
US Patent 8486398 Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds
0
‌
US Patent 10745485 Anti-CD25 antibody agents
0
Patent Primary Examiner
‌
Hong Sang
0
CPC Code
‌
A61P 35/00
0
‌
C07K 2317/732
0
‌
C07K 16/2866
0
Patent abstract

The present disclosure provides antibody sequences found in antibodies that bind to human CD25, in particular an anti CD25-a-674 antibody which do not block the binding of CD25 to IL-2 or IL-2 signalling. The claimed antibody binds to the epitopes: YQCVQGYRALHRGP (150 to 163) or SVCKMTHGKTRWTQP (166 to 180) on CD25 Antibodies and antigen-binding portions thereof including such sequences can be used in pharmaceutical compositions and methods of treatment, in particular for treating cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11873341 Anti-CD25 for tumour specific cell depletion

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.